JiaLiang Tan
ABSTRACT
Heart disease is a highly lethal disease that causes a large number of deaths worldwide every year. When heart disease happened, it will cause the death of a large number of cardiomyocytes. Because of the proliferation capacity of mammalian cardiomyocytes is limited, it's unable for cardiomyocytes to compensate the damage through their own proliferation, resulting in severe damage to the heart function, and ultimately leading to death. Therefore, how to improve the proliferation of cardiomyocytes during the occurrence of heart disease has become a key issue in the study of heart disease. In this review, we discuss the factors that affect the proliferative ability of cardiomyocytes, namely, oxygen concentration, and transcription factors, so as to contribute to the treatment of heart diseases.
- Bensley, J.G., , Impact of preterm birth on the developing myocardium of the neonate. Pediatr Res, 2018. 83(4): p. 880-888.Google Scholar
- Gama-Carvalho, M., J. Andrade, and L. Bras-Rosario, Regulation of Cardiac Cell Fate by microRNAs: Implications for Heart Regeneration. Cells, 2014. 3(4): p. 996-1026.Google Scholar
- Wang, S., , Sex differences in the structure and function of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol, 2020.Google Scholar
- Manfra, O., M. Frisk, and W.E. Louch, Regulation of Cardiomyocyte T-Tubular Structure: Opportunities for Therapy. Curr Heart Fail Rep, 2017. 14(3): p. 167-178.Google Scholar
- Bers, D.M., Cardiac excitation-contraction coupling. Nature, 2002. 415(6868): p. 198-205.Google Scholar
- Steppan, J., , Restoring Blood Pressure in Hypertensive Mice Fails to Fully Reverse Vascular Stiffness. Front Physiol, 2020. 11: p. 824.Google Scholar
- Yu, Y., , Paeonol suppresses the effect of ox-LDL on mice vascular endothelial cells by regulating miR-338-3p/TET2 axis in atherosclerosis. Mol Cell Biochem, 2020.Google ScholarCross Ref
- Shi, J., , Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol, 2020.Google Scholar
- Siamwala, J.H., , Adaptive and innate immune mechanisms in cardiac fibrosis complicating pulmonary arterial hypertension. Physiol Rep, 2020. 8(15): p. e14532.Google ScholarCross Ref
- Shimamura, M., , Progress of Gene Therapy in Cardiovascular Disease. Hypertension, 2020: p. Hypertensionaha12014478.Google Scholar
- Liu, Z.Y., , MicroRNA-144 regulates angiotensin II-induced cardiac fibroblast activation by targeting CREB. Exp Ther Med, 2020. 20(3): p. 2113-2121.Google Scholar
- Bravo-Sagua, R., , Sarcoplasmic reticulum and calcium signaling in muscle cells: Homeostasis and disease. Int Rev Cell Mol Biol, 2020. 350: p. 197-264.Google Scholar
- Matrone, G., C.S. Tucker, and M.A. Denvir, Cardiomyocyte proliferation in zebrafish and mammals: lessons for human disease. Cell Mol Life Sci, 2017. 74(8): p. 1367-1378.Google Scholar
- Jopling, C., , Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature, 2010. 464(7288): p. 606-9.Google Scholar
- Porrello, E.R., , Transient regenerative potential of the neonatal mouse heart. Science, 2011. 331(6020): p. 1078-80.Google Scholar
- Andersen, D.C., C.H. Jensen, and S.P. Sheikh, Comment on "Do Neonatal Mouse Hearts Regenerate following Heart Apex Resection''? Response. Stem Cell Reports, 2014. 3(1).Google Scholar
- Andersen, D.C., , Do Neonatal Mouse Hearts Regenerate following Heart Apex Resection? Stem Cell Reports, 2014. 2(4): p. 406-413.Google Scholar
- Bergmann, O., , Dynamics of Cell Generation and Turnover in the Human Heart. Cell, 2015. 161(7): p. 1566-75.Google Scholar
- Graham, E. and O. Bergmann, Dating the Heart: Exploring Cardiomyocyte Renewal in Humans. Physiology (Bethesda), 2017. 32(1): p. 33-41.Google Scholar
- Zhou, W., , Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J, 2020.Google ScholarCross Ref
- Puente, B.N., , The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell, 2014. 157(3): p. 565-79.Google Scholar
- Kaludercic, N. and F. Di Lisa, Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy. Front Cardiovasc Med, 2020. 7: p. 12.Google ScholarCross Ref
- Wojciechowska, A., A. Braniewska, and K. Kozar-Kaminska, MicroRNA in cardiovascular biology and disease. Advances in Clinical and Experimental Medicine, 2017. 26(5): p. 865-874.Google Scholar
- Thum, T. and M. Mayr, Review focus on the role of microRNA in cardiovascular biology and disease. Cardiovascular Research, 2012. 93(4): p. 543-544.Google Scholar
- Huang, W., , Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nat Commun, 2018. 9(1): p. 700.Google ScholarCross Ref
- Chen, J.H., , mir-17-92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts. Circulation Research, 2013. 112(12): p. 1557-+.Google Scholar
- Muralidhar, S.A. and H.A. Sadek, Meis1 Regulates Postnatal Cardiomyocyte Cell Cycle Arrest, in Etiology and Morphogenesis of Congenital Heart Disease: From Gene Function and Cellular Interaction to Morphology, T. Nakanishi, , Editors. 2016: Tokyo. p. 93-101.Google ScholarCross Ref
- Aksoz, M., , Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer. Current Drug Targets, 2018. 19(2): p. 181-190.Google Scholar
- Mahmoud, A.I., , Meis1 regulates postnatal cardiomyocyte cell cycle arrest. Nature, 2013. 497(7448): p. 249-253.Google Scholar
- Nikoloudaki, G., , Periostin and Matrix Stiffness Combine to Regulate Myofibroblast Differentiation and Fibronectin Synthesis During Palatal Healing. Matrix Biol, 2020.Google Scholar
- Yin, S.L., Z.L. Qin, and X. Yang, Role of periostin in skin wound healing and pathologic scar formation. Chin Med J (Engl), 2020.Google Scholar
- Choi, Y., , Immunohistochemical analysis of periostin in the hearts of Lewis rats with experimental autoimmune myocarditis. J Vet Med Sci, 2020.Google Scholar
- Hudson, J.E. and E.R. Porrello, Periostin paves the way for neonatal heart regeneration. Cardiovasc Res, 2017. 113(6): p. 556-558.Google Scholar
- Shimazaki, M., , Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med, 2008. 205(2): p. 295-303.Google Scholar
Recommendations
Template Factors Affecting Cardiomyocyte Proliferation and Heart Regeneration
ICBBB '22: Proceedings of the 2022 12th International Conference on Bioscience, Biochemistry and BioinformaticsThe heart is one of the most important organs in mammals. The morbidity and fatality rate of heart disease is increasing year by year, and the treatment of the disease also costs people a lot of money. Cardiac diseases such as myocardial infarction will ...
Enhanced delivery of microRNA mimics to cardiomyocytes using ultrasound responsive microbubbles reverses hypertrophy in an in-vitro model
BACKGROUND: Cardiovascular diseases (CVD) account for 36% of deaths in Europe and the United States. Gene therapy can act as a therapeutic modality for the treatment of CVD. The use of microRNA mimetics may be advantageous as they regulate important ...
RNA-Seq Analysis Reveals DPYSL2 and PNKD Promotes Cardiomyocytes Differentiation during Reprogramming
ICCBB '21: Proceedings of the 2021 5th International Conference on Computational Biology and BioinformaticsCardiomyocytes are terminally differentiated cells in the heart, whose injuries leads to severe health issue including cardiac failure and even death. Traditional medical procedure failed to rescue damaged cardiomyocytes and hence cannot cure severe ...
Comments